Skip to main content

Five Oceans Advisors

Position in NVO — Novo Nordisk A S

CIK 1876326 SANTA MONICA, CA

Position in NVO

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$354,564
+$100,732 QoQ
Shares Held
7,396
+7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#834
of 1,348 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Five Oceans Advisors holds $7,614,351 across 12 Drug Manufacturers - General names. NVO ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
7,396 $354,564

All Filings in NVO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $354,564 7,396
2026-03-31 $253,832 6,907
2025-12-31 $287,319 5,647
2025-09-30 $491,641 8,860
2025-06-30 $1,087,893 15,762
2025-03-31 $1,390,536 20,025
2024-12-31 $1,722,550 20,025
2024-09-30 $2,384,376 20,025
2024-06-30 $2,858,368 20,025
2024-03-31 $2,881,552 22,442
2023-12-31 $2,321,624 22,442
2023-09-30 $2,363,166 25,986
2023-06-30 $2,102,657 12,993
2023-03-31 $2,700,446 16,969
2022-12-31 $2,296,584 16,969
2022-09-30 $1,690,621 16,969
2022-06-30 $1,454,050 13,049
2022-03-31 $1,358,141 12,230
2021-12-31 $1,035,664 9,247
2021-09-30 $570,299 5,940